The TiLOOP® male sling

• Verfasst von: Hüsch, Tanja [VerfasserIn]
• Verfasst von: Kretschmer, Alexander Dennis Rudolf [VerfasserIn]
• Verfasst von: Nyarangi-Dix, Joanne [VerfasserIn]
• Titel: The TiLOOP® male sling
• Titelzusatz: did we forejudge
• Verf.angabe: Tanja Hüsch, Alexander Kretschmer, Frauke Thomsen, Dominik Kronlachner, Martin Kurosch, Alice Obaje, Ralf Anding, Ruth Kirschner-Hermanns, Tobias Pottek, Achim Rose, Roberto Olianas, Alexander Friedl, Wilhelm Hübner, Roland Homberg, Jesco Pfitzenmaier, Ulrich Grein, Fabian Queissert, Carsten Maik Naumann, Josef Schweiger, Carola Wotzka, Joanne Nyarangi-Dix, Bernhard Brehmer, Kurt Ulm, Ricarda M. Bauer, Axel Haferkamp, Debates On Male Incontinence (DOMINO)-Project 8
• Jahr: 2018
• Umfang: 6 S.
• Fussnoten: Published online: October 26, 2017 ; Gesehen am 05.11.2019
• Titel Quelle: Enthalten in: Urologia internationalis
• Ort Quelle: Basel : Karger, 1955
• Jahr Quelle: 2018
• Band/Heft Quelle: 100(2018), 2, Seite 216-221
• ISSN Quelle: 1423-0399
• DOI: doi:10.1159/000477765
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1681038641

Abstract

<b><i>Introduction:</i></b> To evaluate the safety and efficacy of the TiLOOP® male sling (pfm medical, Cologne, Germany) used in the treatment for male stress urinary incontinence (SUI). <b><i>Material and Methods:</i></b> We retrospectively evaluated a total of 34 patients with a TiLOOP® male sling. Perioperative complication rates were assessed and validated questionnaires were prospectively evaluated to assess quality of life and satisfaction rate. Outcome and complication rates were analysed by using descriptive statistics. Correlation of continence outcome and risk factors was performed with the chi-square test. A <i>p</i> value below 0.05 was considered statistically significant. <b><i>Results:</i></b> The majority of patients (70.6%) were diagnosed with mild or moderate male SUI. During surgery, one instance (2.9%) of intraoperative urethral injury was observed. There were no immediate postoperative complications. The mean follow-up time was 44.6 months. An improvement of male SUI was reported by 61.9% of the patients and 38.1% reported no change according the Patient Global Impression of Improvement. The mean perineal pain score was 0.5 according to the international index of pain. <b><i>Conclusions: </i></b>The TiLOOP® is a safe treatment option for male SUI in our cohort with a low complication rate. However, the functional outcome of the TiLOOP® was inferior when compared to the outcome of the AdVance® male sling.